34566527|PMC8451396
{'Disease'}
We examine whether diversification is valuable in reducing the cost of debt for COVID-19-exposed firms. Consistent with this, documents that firms with complex corporate structures pay higher loan spreads. First, it adds to the results of studies on the debt market effects of COVID-19 exposure (e.g.,), particularly those documenting that the pandemic has increased borrowing costs, by providing novel evidence that the increase in borrowing costs for COVID-19-exposed firms depends on the firms' diversification.